We have received an uptick in questions related to this substance. We felt it was best to share our policy here to bring attention to it. . OCB adheres to WADA guidelines FDA takes first step in possible reversal of ban on some peptides The Washington Post BPC 157: Miracle Healing Peptide or Hidden Danger? FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and BPC 157 erectile dysfunction study: what the current evidence actually shows